ISCT 2020 – VJRegenMed

Respiratory pathology of COVID-19 and potential for MSCs

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Mauro Krampera, MD, PhD, of the University of Verona, Verona, Italy, discusses the pathogenesis of COVID-19 and the potential benefit of administrating mesenchymal stromal cells (MSCs) based on outcomes of patients with inflammatory disorders treated using this approach. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

Functional vascular grafts from human pluripotent stem cell-derived endothelial cells

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Gabor Foldes, MD, PhD, of the National Heart and Lung Institute, Imperial College London, London, UK, discusses a novel model involving building functional cardiovascular grafts from human pluripotent stem-cell derived endothelial cells and its potential future clinical applications. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

Clinical applications of stem cell therapies

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Marc Peschanski, MD, PhD, of the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem), Paris, France, discusses the scientific basis and clinical applications of stem cell therapies. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

Whole-liver bioengineering: the future of transplantation medicine

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Pedro Baptista, PharmD, PhD, of Aragon Health Research Institute, Zaragoza, Spain, outlines whole-liver bioengineering as the future of transplantation and challenges associated with its implementation. Specifically discussed is how dis-used organs can be decellularized and recapitulated with patient-derived tissue to generate new organs that are eligible for transplantation. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

Main areas of progress in stem cell therapies

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Marc Peschanski, MD, PhD, of the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem), Paris, France, outlines advances in stem cell therapies and clinical trials evaluating their use. Specifically discussed are pluripotent stem cells and their capacity to differentiate into retinal pigmented epithelial cells, and the potential advantages of their use. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

Functional dosing of MSC-derived extracellular vesicles for the prevention of GvHD

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Mauro Krampera, MD, PhD, of the University of Verona, Verona, Italy, outlines the use of mesenchymal stromal cell (MSC)-derived extracellular vesicles for the prevention of acute graft-versus-host disease (GvHD). This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

State of the art: cardiovascular regenerative medicine

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Gabor Foldes, MD, PhD, of the National Heart and Lung Institute, Imperial College London, London, UK, explores current research efforts in cardiovascular regenerative medicine. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

Limitations in the application of stem cell therapies

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Marc Peschanski, MD, PhD, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem), Paris, France, explores limitations in implementing stem cell therapies into clinical practice as well as next steps to approach these challenges. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

Current research in regenerative medicine

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Marc Peschanski, MD, PhD, of the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem), Paris, France, discusses historical approaches in regenerative medicine as well as current experimental directions being investigated. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

Renin producing human kidney organoids

admin_vjr_user — Wed, 19 Aug 2020 16:20:19 +0000

Anushka Shankar, MD, MSc, of Erasmus University Rotterdam, Rotterdam, the Netherlands, discusses the development of human kidney organoids from stem cells, that can restore the endocrine system, including renin production. Furthermore, Dr. Shankar outlines the next steps in research, including determining how physiological interactions may affect renin production. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).